163 related articles for article (PubMed ID: 22668778)
1. LRRK2 kinase activity mediates toxic interactions between genetic mutation and oxidative stress in a Drosophila model: suppression by curcumin.
Yang D; Li T; Liu Z; Arbez N; Yan J; Moran TH; Ross CA; Smith WW
Neurobiol Dis; 2012 Sep; 47(3):385-92. PubMed ID: 22668778
[TBL] [Abstract][Full Text] [Related]
2. Inhibitors of LRRK2 kinase attenuate neurodegeneration and Parkinson-like phenotypes in Caenorhabditis elegans and Drosophila Parkinson's disease models.
Liu Z; Hamamichi S; Lee BD; Yang D; Ray A; Caldwell GA; Caldwell KA; Dawson TM; Smith WW; Dawson VL
Hum Mol Genet; 2011 Oct; 20(20):3933-42. PubMed ID: 21768216
[TBL] [Abstract][Full Text] [Related]
3. The Drosophila hep pathway mediates Lrrk2-induced neurodegeneration.
Yang D; Thomas JM; Li T; Lee Y; Liu Z; Smith WW
Biochem Cell Biol; 2018 Aug; 96(4):441-449. PubMed ID: 29268033
[TBL] [Abstract][Full Text] [Related]
4. The role of tyrosine hydroxylase-dopamine pathway in Parkinson's disease pathogenesis.
Zhou ZD; Saw WT; Ho PGH; Zhang ZW; Zeng L; Chang YY; Sun AXY; Ma DR; Wang HY; Zhou L; Lim KL; Tan EK
Cell Mol Life Sci; 2022 Nov; 79(12):599. PubMed ID: 36409355
[TBL] [Abstract][Full Text] [Related]
5. LRRK2 enhances oxidative stress-induced neurotoxicity via its kinase activity.
Heo HY; Park JM; Kim CH; Han BS; Kim KS; Seol W
Exp Cell Res; 2010 Feb; 316(4):649-56. PubMed ID: 19769964
[TBL] [Abstract][Full Text] [Related]
6. Thiol peroxidases ameliorate LRRK2 mutant-induced mitochondrial and dopaminergic neuronal degeneration in Drosophila.
Angeles DC; Ho P; Chua LL; Wang C; Yap YW; Ng C; Zhou Zd; Lim KL; Wszolek ZK; Wang HY; Tan EK
Hum Mol Genet; 2014 Jun; 23(12):3157-65. PubMed ID: 24459295
[TBL] [Abstract][Full Text] [Related]
7. Vacuolar protein sorting 35 (Vps35) rescues locomotor deficits and shortened lifespan in Drosophila expressing a Parkinson's disease mutant of Leucine-Rich Repeat Kinase 2 (LRRK2).
Linhart R; Wong SA; Cao J; Tran M; Huynh A; Ardrey C; Park JM; Hsu C; Taha S; Peterson R; Shea S; Kurian J; Venderova K
Mol Neurodegener; 2014 Jun; 9():23. PubMed ID: 24915984
[TBL] [Abstract][Full Text] [Related]
8. LRRK2 controls an EndoA phosphorylation cycle in synaptic endocytosis.
Matta S; Van Kolen K; da Cunha R; van den Bogaart G; Mandemakers W; Miskiewicz K; De Bock PJ; Morais VA; Vilain S; Haddad D; Delbroek L; Swerts J; Chávez-Gutiérrez L; Esposito G; Daneels G; Karran E; Holt M; Gevaert K; Moechars DW; De Strooper B; Verstreken P
Neuron; 2012 Sep; 75(6):1008-21. PubMed ID: 22998870
[TBL] [Abstract][Full Text] [Related]
9. Leucine-rich repeat kinase 2 disturbs mitochondrial dynamics via Dynamin-like protein.
Niu J; Yu M; Wang C; Xu Z
J Neurochem; 2012 Aug; 122(3):650-8. PubMed ID: 22639965
[TBL] [Abstract][Full Text] [Related]
10. RAB7L1 interacts with LRRK2 to modify intraneuronal protein sorting and Parkinson's disease risk.
MacLeod DA; Rhinn H; Kuwahara T; Zolin A; Di Paolo G; McCabe BD; Marder KS; Honig LS; Clark LN; Small SA; Abeliovich A
Neuron; 2013 Feb; 77(3):425-39. PubMed ID: 23395371
[TBL] [Abstract][Full Text] [Related]
11. Temporal expression of mutant LRRK2 in adult rats impairs dopamine reuptake.
Zhou H; Huang C; Tong J; Hong WC; Liu YJ; Xia XG
Int J Biol Sci; 2011; 7(6):753-61. PubMed ID: 21698001
[TBL] [Abstract][Full Text] [Related]
12. Knockdown transgenic Lrrk Drosophila resists paraquat-induced locomotor impairment and neurodegeneration: A therapeutic strategy for Parkinson's disease.
Quintero-Espinosa D; Jimenez-Del-Rio M; Velez-Pardo C
Brain Res; 2017 Feb; 1657():253-261. PubMed ID: 28041945
[TBL] [Abstract][Full Text] [Related]
13. Loss of LRRK2/PARK8 induces degeneration of dopaminergic neurons in Drosophila.
Lee SB; Kim W; Lee S; Chung J
Biochem Biophys Res Commun; 2007 Jun; 358(2):534-9. PubMed ID: 17498648
[TBL] [Abstract][Full Text] [Related]
14. Effects of sevoflurane on leucine-rich repeat kinase 2-associated Drosophila model of Parkinson's disease.
Shan Z; Cai S; Zhang T; Kuang L; Wang Q; Xiu H; Wen J; Gu H; Xu K
Mol Med Rep; 2015 Mar; 11(3):2062-70. PubMed ID: 25406035
[TBL] [Abstract][Full Text] [Related]
15. Evidence that the LRRK2 ROC domain Parkinson's disease-associated mutants A1442P and R1441C exhibit increased intracellular degradation.
Greene ID; Mastaglia F; Meloni BP; West KA; Chieng J; Mitchell CJ; Gai WP; Boulos S
J Neurosci Res; 2014 Apr; 92(4):506-16. PubMed ID: 24375786
[TBL] [Abstract][Full Text] [Related]
16. The chaperone activity of heat shock protein 90 is critical for maintaining the stability of leucine-rich repeat kinase 2.
Wang L; Xie C; Greggio E; Parisiadou L; Shim H; Sun L; Chandran J; Lin X; Lai C; Yang WJ; Moore DJ; Dawson TM; Dawson VL; Chiosis G; Cookson MR; Cai H
J Neurosci; 2008 Mar; 28(13):3384-91. PubMed ID: 18367605
[TBL] [Abstract][Full Text] [Related]
17. Genetic dissection reveals that Akt is the critical kinase downstream of LRRK2 to phosphorylate and inhibit FOXO1, and promotes neuron survival.
Chuang CL; Lu YN; Wang HC; Chang HY
Hum Mol Genet; 2014 Nov; 23(21):5649-58. PubMed ID: 24916379
[TBL] [Abstract][Full Text] [Related]
18. Phosphorylation of 4E-BP by LRRK2 affects the maintenance of dopaminergic neurons in Drosophila.
Imai Y; Gehrke S; Wang HQ; Takahashi R; Hasegawa K; Oota E; Lu B
EMBO J; 2008 Sep; 27(18):2432-43. PubMed ID: 18701920
[TBL] [Abstract][Full Text] [Related]
19. (R1441C) LRRK2 induces the degeneration of SN dopaminergic neurons and alters the expression of genes regulating neuronal survival in a transgenic mouse model.
Weng YH; Chen CY; Lin KJ; Chen YL; Yeh TH; Hsiao IT; Chen IJ; Lu CS; Wang HL
Exp Neurol; 2016 Jan; 275 Pt 1():104-15. PubMed ID: 26363496
[TBL] [Abstract][Full Text] [Related]
20. LRRK2 kinase regulates synaptic morphology through distinct substrates at the presynaptic and postsynaptic compartments of the Drosophila neuromuscular junction.
Lee S; Liu HP; Lin WY; Guo H; Lu B
J Neurosci; 2010 Dec; 30(50):16959-69. PubMed ID: 21159966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
